INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 202 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $675,488 | -31.9% | 61,075 | -17.2% | 0.00% | -50.0% |
Q1 2023 | $991,213 | +29.9% | 73,806 | +19.7% | 0.00% | 0.0% |
Q4 2022 | $762,833 | +0.4% | 61,668 | +12.9% | 0.00% | 0.0% |
Q3 2022 | $760,000 | +12.8% | 54,603 | +11.7% | 0.00% | +100.0% |
Q2 2022 | $674,000 | -22.3% | 48,886 | -8.4% | 0.00% | -50.0% |
Q1 2022 | $867,000 | -22.6% | 53,385 | -22.5% | 0.00% | 0.0% |
Q4 2021 | $1,120,000 | -2.0% | 68,845 | -10.6% | 0.00% | 0.0% |
Q3 2021 | $1,143,000 | -28.0% | 77,037 | -3.1% | 0.00% | -33.3% |
Q2 2021 | $1,587,000 | +37.2% | 79,483 | +58.3% | 0.00% | +50.0% |
Q1 2021 | $1,157,000 | -61.4% | 50,206 | -58.7% | 0.00% | -66.7% |
Q4 2020 | $2,998,000 | -60.8% | 121,441 | -34.1% | 0.01% | -62.5% |
Q3 2020 | $7,639,000 | +280.8% | 184,213 | +339.6% | 0.02% | +300.0% |
Q2 2020 | $2,006,000 | +60.6% | 41,903 | +111.0% | 0.00% | +33.3% |
Q1 2020 | $1,249,000 | -50.9% | 19,860 | -3.4% | 0.00% | -40.0% |
Q4 2019 | $2,546,000 | +111.5% | 20,561 | +13.3% | 0.01% | +150.0% |
Q3 2019 | $1,204,000 | +60100.0% | 18,154 | +60413.3% | 0.00% | – |
Q4 2017 | $2,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | -99.9% | 30 | -99.8% | 0.00% | -100.0% |
Q2 2017 | $1,706,000 | +2.7% | 14,092 | -4.0% | 0.00% | 0.0% |
Q1 2017 | $1,661,000 | +16.2% | 14,683 | +12.2% | 0.00% | 0.0% |
Q4 2016 | $1,429,000 | – | 13,083 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |